Glenmark pharma News: Glenmark pharma Latest News, Glenmark pharma Today news, Glenmark pharma Breaking News

A financial trading terminal displaying the Nifty Pharma Index drop alongside a visual timeline breakdown of Donald Trump's phased tariff policy on generic drug imports—showing 0% duty until August 2028, 100% in 2028–2029, and 200% from August 2029 onward.

Pharma stocks fall after Trump’s 200% tariff announcement for generic imports: Experts decode what it means

Track pharma stocks as Trump’s phased US tariff plan hits sentiment, though analysts say India’s cost edge may cushion generic…

July 22, 2026 10:36 IST

HSBC sees Glenmark gaining after US FDA nod boosts inhaler pipeline

Glenmark Pharma: HSBC sees 21% upside after ‘first-to-market’ US FDA win

A key US drug approval is putting this pharma stock back on the radar, with a global brokerage pointing to…

Updated: March 18, 2026 14:12 IST

Buy these stocks in November and sell in December

Seasonality suggests November softness and December strength, yet select Pharma counters consistently outperform. Three stocks offering the favourable risk-reward from…

November 11, 2025 05:30 IST

This pharma multibagger stock delivered 435% return in 3 years: Declares interim dividend – Do you own?

Glenmark Pharma declares Rs 2.50 interim dividend as shares deliver 435% gain in 3 years—check if you qualify for payout!

October 1, 2025 17:09 IST

ICICI Lombard Dividend 2025: Check record date, eligibility, and other key details

Dividend stocks: Glenmark Pharma only stock to trade ex-dividend this week

Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; watch for interim Rs 2.5 payout. Check…

September 28, 2025 07:00 IST

Nifty Pharma index today, Nifty Pharma down, Indian pharma stocks fall

Pharma stocks crack, Nifty Pharma Index slips over 2% as Trump unveils 100% tariff: 3 key factors investors must watch

Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…

September 26, 2025 11:50 IST

Nomura on Glenmark Pharma today, September 25

More pain ahead for Glenmark Pharma? 3 reasons why Nomura sees 25% downside after licencing deal for cancer drug

Discover why Nomura predicts a 25% downside for Glenmark Pharma despite its new cancer drug deal—read their analysis before investing!

September 25, 2025 10:54 IST

From Tata Steel, Waaree Energies to Piramal Enterprises – Here are 9 stocks to watch today

Track Tata Steel, Akzo Nobel, Piramal Enterprises and more for key M&A, deals, and market moves—see which stocks to watch…

September 25, 2025 06:33 IST

Glenmark inks exclusive licensing pact with Hengrui for next-gen cancer drug; to make $18 m upfront payment

Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals, signed an exclusive $1.1 bn licensing deal with Hengrui Pharma for Trastuzumab…

September 24, 2025 17:23 IST

TCS share price fall, Glenmark stock rally

Stocks making the biggest moves midday: Glenmark, TCS, BSE & more

Discover why shares like Glenmark and TCS are making major moves amid market pressure – find out which stocks are…

July 11, 2025 15:00 IST

Motilal Oswal’s 3 ‘Buy’ recommendations in a falling market; upside potential as much as 28%

Motilal Oswal sees up to 28% upside in TCS, Suzlon, and Glenmark Pharma – review their top stock picks now…

July 11, 2025 14:25 IST

AbbVie signs $700 million deal with IGI Therapeutics to co-develop new multiple myeloma drug ISB 2001

Big news: AbbVie inks $700 million pact with Glenmark arm to develop and sell new cancer drug

AbbVie has entered into a $700 million licensing agreement with IGI Therapeutics to co-develop ISB 2001, a promising trispecific T-cell…

July 11, 2025 11:05 IST

Glenmark to introduce Brukinsa in India to treat five types of B-cell blood cancers

Glenmark to launch Blood Cancer drug, Brukinsa in India; gets DCGI approval

Glenmark Pharmaceuticals to launch Brukinsa (zanubrutinib) in India after DCGI approval, offering treatment for five B-cell blood cancers with fewer…

June 9, 2025 17:32 IST

stocks to watch, stock in news, stocks in news, stocks to know

Stocks to watch today: From Grasim Industries, HCL Tech to Biocon – Here are 7 stocks in focus today

Watch top stocks today: Grasim, HCL, Biocon and more as they make key moves and announcements. Explore the detailed insights…

June 3, 2025 06:39 IST

Ashish Dhawan, known as India's Warren Buffett, holds a portfolio worth over ₹3,004 crore. (Image Source: Canva)

2 Favourite stocks of this Warren Buffett of India are trading at a discount…

When a super investor of India or like we call them, Warren Buffetts of India is interested in a stock/company,…

May 7, 2025 05:30 IST

Motilal Oswal top picks, vehicle finance stocks, GST cut vehicles, Shriram Finance share price, Cholamandalam Finance stock, Mahindra Finance stock, vehicle finance sector India

Stocks To Watch: From TCS, Swiggy, Coforge to Glenmark Pharma- Here are 9 stocks to watch

Stocks to watch today, May 06: GIFT Nifty was trading up 0.14% to 24,597, which indicates a higher start for…

May 6, 2025 06:44 IST

Motilal Oswal has Buy recommendations on these 3 stocks

Motilal Oswal recommends buying UltraTech, Glenmark, and Zen Tech for strong growth. Explore their potential now!

February 18, 2025 12:50 IST

Stocks To Watch: From BHEL to Glenmark Pharma- Here’s a list of 10 stocks to track today

Watch BHEL, MTNL, and Glenmark Pharma for market shifts today. Explore why these stocks are in focus!

February 17, 2025 06:24 IST

Glenmark Pharma

Related News

Trending Topics